Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales

August 7, 2023 updated by: Vastra Gotaland Region

The latissimus dorsi flap is the oldest and most used technique for breast reconstruction. Nonetheless, there are few studies evaluation the long-term effect of harvesting one of the muscles of the back. This project has four parts.

  1. Validation of scales/instrument for Swedish.
  2. Long-term results after reconstruction with latissimus dorsi- a ten year retrospective follow-up.
  3. Thoracodorsal artery perforator flap (TDAP) vs latissimus dorsi flap- a randomized controlled trial - breast reconstruction.
  4. TDAP vs Limber flap - a randomized controlled trial- reconstruction of axillary hidradenitis suppurativa.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

550

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Gothenburg, Sweden, 413 45
        • Recruiting
        • Sahlgrenska University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  • Patients eligible for breast reconstruction following mastectomy and radiation
  • Non-smokers or ex-smokers (>6 weeks)
  • BMI < 30

Exclusion Criteria:

  • Inability to leave informed consent
  • Inability to understand Swedish
  • Previous surgery with scaring on back

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Breast reconstruction TDAP
Breast reconstruction performed with TDAP
Breast reconstruction
Other Names:
  • TDAP
Active Comparator: Breast reconstruction latissimus dorsi
Breast reconstruction performed with latissimus dorsi
Breast reconstruction
Other Names:
  • LD flap
Active Comparator: Breast reconstruction with DIEP
Breast reconstruction performed with a deep inferior epigastric artery perforator flap
Breast reconstruction
Other Names:
  • DIEP flap

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction and breast-related quality of life after breast reconstruction
Time Frame: 10 years
Breast Q reconstruction.The BREAST-Q has multiple domains, each scored from 0 to 100 (higher scores indicate greater satisfaction or quality of life), there is no overall BREAST-Q score.
10 years
Back and shoulder function after breast reconstruction
Time Frame: 10 years
Breast Q the back and shoulder function scale. The scale is scored from 0 (worst) to 100 (best). Higher scores reflect a better outcome.
10 years
Back appearance after breast reconstruction
Time Frame: 10 years
Breast-Q the back appearance scale.The scale is scored from 0 (worst) to 100 (best). Higher scores reflect a better outcome.
10 years
Shoulder function after breast reconstruction
Time Frame: 10 years
Western Ontario Osteoarthritis of the shoulder index (WOOS) provides scores on four domains: (1) physical symptoms; (2) sport, recreation, and work; (3) lifestyle; and (4) emotions.Each question has a possible score from 0-100 giving a total score up to 1900. The highest or most symptomatic score is 1900 and the best or asymptomatic score is 0.
10 years
Abdominal satisfaction after breast reconstruction
Time Frame: 10 years
Breast Q abdominal satisfaction and abdominal well-being.The scale is scored from 0 (worst) to 100
10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications after breast reconstruction
Time Frame: 2 years
Measured in patients randomized to TDAP or latissimus dorsi flap.
2 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Validation of Breast Q: The Back Appearance scale for Swedish
Time Frame: 1 year
Translation and validation of the instrument for Swedish
1 year
Validation of Breast-Q: The back and shoulder function scale for Swedish
Time Frame: 1 year
Translation and validation of the instrument for Swedish
1 year
Normal material for Breast-Q
Time Frame: 5 years
Measurement of quality of life according to breast-Q in a normative population
5 years
Normal material for Breast-Q back appearance scale
Time Frame: 5 years
Measurement of quality of life according to breast-Q back appaearance scale in a normative population
5 years
Normal material for Breast-Q back and shoulder function scale
Time Frame: 5 years
Measurement of quality of life according to breast-Q back and shoulder function scale in a normative population
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2020

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

August 12, 2020

First Submitted That Met QC Criteria

August 24, 2020

First Posted (Actual)

August 26, 2020

Study Record Updates

Last Update Posted (Actual)

August 8, 2023

Last Update Submitted That Met QC Criteria

August 7, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 254-18

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Thoracodorsal artery perforator flap to breast

3
Subscribe